Levofloxacin Approved for Treatment of Plague - Medscape
CBS NewsLevofloxacin Approved for Treatment of PlagueMedscapeMay 1, 2012 — The fluoroquinolone antibiotic levofloxacin (Levaquin, Janssen Pharmaceuticals Inc) has been approved as part of a US Food and Drug Administration (FDA) priority review application for the treatment of plague.
Achaogen's plazomicin and levofloxacin safe and effective in treating cUTI ... - News-Medical.net
Achaogen's plazomicin and levofloxacin safe and effective in treating cUTI .
Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of ... - MarketWatch (press release)
Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of .
Popular Antibiotic May Raise Risk of Sudden Death - New York Times
New York TimesPopular Antibiotic May Raise Risk of Sudden DeathNew York TimesThe death rates with azithromycin and levofloxacin were about the same (earlier studies have linked levofloxacin to abnormal heart rhythms), and were higher than the rate with ciprofloxacin.
Cempra, Inc. Reports First Quarter 2012 Financial and Operating Results - MarketWatch (press release)